TITLE
Methotrexate-resistant HT29 colon adenocarcinoma cell line

SUMMARY
Analysis of HT29 colon cancer cells sensitive or resistant to methotrexate (MTX). MTX is used in the treatment of cancer. Chemotherapy effectiveness in cancer cells is compromised by development of drug resistance. Results provide insight into molecular mechanisms associated with drug resistance.

ORGANISM
Homo sapiens

PLATFORM
GPL570 : [HG-U133_Plus_2] Affymetrix Human Genome U133 Plus 2.0 Array

CITATIONS
Selga E, Morales C, Noé V, Peinado MA et al. Role of caveolin 1, E-cadherin, Enolase 2 and PKCalpha on resistance to methotrexate in human HT29 colon cancer cells. BMC Med Genomics 2008 Aug 11;1:35. PMID:  18694510 Selga E, Oleaga C, Ramírez S, de Almagro MC et al. Networking of differentially expressed genes in human cancer cells resistant to methotrexate. Genome Med 2009 Sep 4;1(9):83. PMID:  19732436 Mencia N, Selga E, Noé V, Ciudad CJ. Underexpression of miR-224 in methotrexate resistant human colon cancer cells. Biochem Pharmacol 2011 Dec 1;82(11):1572-82. PMID:  21864507

